Literature DB >> 6966607

Serum protein concentrations during Schistosoma mansoni infection in intact and T-cell deprived mice. I. The acute phase proteins, C3 and serum amyloid P-component (SAP).

M B Pepys, M L Baltz, R Musallam, M J Doenhoff.   

Abstract

Normal mice developed marked elevation of two acute phase plasma proteins, C3 and serum amyloid P-component (SAP), between 40 and 50 days after percutaneous infection with cercariae of Schistosoma mansoni. The high levels persisted until the end of the experiment (day 106). The onset of this acute phase response corresponds with the reported time at which granulomata develop in the liver. In mice deprived of T cells by thymectomy and anti-thymocyte serum, the granulomata were significantly smaller and all the animals died between days 70 and 80. These mice had normal C3 levels throughout although there was a rise in SAP concentration. C3 and SAP levels in infected control mice, which had been thymectomized but not deprived of T cells with anti-thymocyte serum, were the same as in intact infected animals. The different behaviour of C3 and SAP in infected T-cell deprived mice may reflect the alteration in specific schistosomal pathology and/or a role for T cells in mediation of the acute phase production of some proteins.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6966607      PMCID: PMC1457973     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  31 in total

Review 1.  Immunoglobulin-producing tumors and myeloma proteins of mice.

Authors:  M Potter
Journal:  Physiol Rev       Date:  1972-07       Impact factor: 37.312

2.  Specificity of C-reactive protein for choline phosphate residues of pneumococcal C-polysaccharide.

Authors:  J E Volanakis; M H Kaplan
Journal:  Proc Soc Exp Biol Med       Date:  1971-02

3.  Antigenic and C-substance activities of related glycopeptides from fungal, parasitic and vegetable sources.

Authors:  J Pepys; J L Longbottom
Journal:  Int Arch Allergy Appl Immunol       Date:  1971

4.  Depletion of plasma complement in vivo by a protein of cobra venom: its effect on various immunologic reactions.

Authors:  C G Cochrane; H J Müller-Eberhard; B S Aikin
Journal:  J Immunol       Date:  1970-07       Impact factor: 5.422

5.  Conditions affecting the accuracy of potassium hydroxide digestion techniques for counting Schistosoma mansoni eggs in tissues.

Authors:  A W Cheever
Journal:  Bull World Health Organ       Date:  1968       Impact factor: 9.408

6.  The infection of laboratory hosts with cercariae of Schistosoma mansoni and the recovery of the adult worms.

Authors:  S R Smithers; R J Terry
Journal:  Parasitology       Date:  1965-11       Impact factor: 3.234

7.  Interaction of C-reactive protein complexes with the complement system. I. Consumption of human complement associated with the reaction of C-reactive protein with pneumococcal C-polysaccharide and with the choline phosphatides, lecithin and sphingomyelin.

Authors:  M H Kaplan; J E Volanakis
Journal:  J Immunol       Date:  1974-06       Impact factor: 5.422

8.  Mouse C-reactive protein and endotoxin-induced resistance.

Authors:  L T Patterson; R D Higginbotham
Journal:  J Bacteriol       Date:  1965-12       Impact factor: 3.490

9.  Association of C-reactive protein and circulating leukocytes with resistance to Staphylococcus aureus infection in endotoxin-treated mice and rabbits.

Authors:  L T Patterson; J M Harper; R D Higginbotham
Journal:  J Bacteriol       Date:  1968-04       Impact factor: 3.490

10.  Schistosoma mansoni infection in mice depleted of thymus-dependent lymphocytes. II. Pathology and altered pathogenesis.

Authors:  R D Buchanan; D P Fine; D G Colley
Journal:  Am J Pathol       Date:  1973-05       Impact factor: 4.307

View more
  9 in total

1.  IgG receptor FcγRIIB plays a key role in obesity-induced hypertension.

Authors:  Nathan C Sundgren; Wanpen Vongpatanasin; Brigid-Meghan D Boggan; Keiji Tanigaki; Ivan S Yuhanna; Ken L Chambliss; Chieko Mineo; Philip W Shaul
Journal:  Hypertension       Date:  2014-11-03       Impact factor: 10.190

2.  Detection of alpha 2-macroglobulin, alpha 1-protease inhibitor, and neutral protease-antiprotease complexes within liver granulomas of Schistosoma mansoni-infected mice.

Authors:  J L Truden; D L Boros
Journal:  Am J Pathol       Date:  1988-02       Impact factor: 4.307

3.  C3 levels in the sera of rabbits infested and reinfested with Ixodes ricinus L. and in midguts of fed ticks.

Authors:  V Papatheodorou; M Brossard
Journal:  Exp Appl Acarol       Date:  1987-03       Impact factor: 2.132

4.  Effect of ultraviolet radiation on production of epidermal cell thymocyte-activating factor/interleukin 1 in vivo and in vitro.

Authors:  L Gahring; M Baltz; M B Pepys; R Daynes
Journal:  Proc Natl Acad Sci U S A       Date:  1984-02       Impact factor: 11.205

5.  Kinetics of interleukin-6 production after experimental infection of mice with Schistosoma mansoni.

Authors:  R M Khalil; L Hültner; R Mailhammer; A Luz; J Moeller; A A Mohamed; S Omran; P Dörmer
Journal:  Immunology       Date:  1996-10       Impact factor: 7.397

6.  Acute local inflammation alters synthesis, distribution, and catabolism of third component of complement (C3) in rabbits.

Authors:  U Manthei; R C Strunk; P C Giclas
Journal:  J Clin Invest       Date:  1984-08       Impact factor: 14.808

7.  Serum protein concentrations during Schistosoma mansoni infection in intact and T-cell deprived mice. II. Immunoglobulin G and antibodies specific for heterologous erythrocytes.

Authors:  R Musallam; J Bain; A McGregor; M Doenhoff
Journal:  Immunology       Date:  1980-07       Impact factor: 7.397

Review 8.  Human schistosomiasis: clinical perspective: review.

Authors:  Rashad S Barsoum; Gamal Esmat; Tamer El-Baz
Journal:  J Adv Res       Date:  2013-04-03       Impact factor: 10.479

9.  Persistent lung inflammation and fibrosis in serum amyloid P component (APCs-/-) knockout mice.

Authors:  Darrell Pilling; Richard H Gomer
Journal:  PLoS One       Date:  2014-04-02       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.